Unknown NA INTERVENTIONAL 2-arm NCT03612440

Effects of Dexmedetomidine on OI, RI and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty.

Effects of Dexmedetomidine on Oxygenation Index, Respiratory Index and Inflammatory Factors in Patients Undergoing Palatopalatyngoplasty

Sponsor: General Hospital of Ningxia Medical University

Conditions Adverse Effect

Interventions dexmedetomidine normal saline

Updated 5 times since 2018 Last updated: Aug 1, 2018 Started: Aug 1, 2018 Primary completion: Apr 30, 2019 Completion: Apr 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03612440, this NA trial focuses on Adverse Effect and remains ongoing. Sponsored by General Hospital of Ningxia Medical University, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Sep 2018 — Sep 2020 [monthly]

Not Yet Recruiting NA

First recorded

Aug 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

General Hospital of Ningxia Medical University

Data source: General Hospital of Ningxia Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yinchuan, China